Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

Mark S. Pearson; Darren A. Pickering; Henry J. McSorley; Jeffrey M. Bethony; Leon Tribolet; Annette M. Dougall; Peter J. Hotez; Alex Loukas

doi:10.1371/journal.pntd.0001564

Loading metrics

Open Access

Peer-reviewed

Research Article

Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

Mark S. Pearson,

Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia
⨯
Darren A. Pickering,

Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia
⨯
Henry J. McSorley,

Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia
⨯
Jeffrey M. Bethony,

Affiliation Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington D.C., United States of America
⨯
Leon Tribolet,

Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia
⨯
Annette M. Dougall,

Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia
⨯
Peter J. Hotez,

Affiliation Department of Pediatrics and Molecular Virology and Microbiology, and National School of Tropical Medicine, Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, Texas, United States of America
⨯
Alex Loukas

* E-mail: alex.loukas@jcu.edu.au

Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia
⨯

Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

Mark S. Pearson,
Darren A. Pickering,
Henry J. McSorley,
Jeffrey M. Bethony,
Leon Tribolet,
Annette M. Dougall,
Peter J. Hotez,
Alex Loukas

Published: March 13, 2012
https://doi.org/10.1371/journal.pntd.0001564

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Schistosoma mansoni
Is the Subject Area "Schistosoma mansoni" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Schistosomiasis
Is the Subject Area "Schistosomiasis" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Eggs
Is the Subject Area "Eggs" applicable to this article?

Thanks for your feedback.